Shuttle Pharmaceuticals announces 1-for-10 reverse stock split effective June 11, 2026

Shuttle Pharmaceuticals Holdings, Inc.

Board approved 1:10 reverse split of common stock, effective June 11, 2026.
Every ten pre-split shares combine into one; no fractional shares issued (round up to whole share).
Authorized shares unchanged; exercise prices of warrants, RSUs, and convertible preferred adjusted proportionally.
New CUSIP number for post-split common stock is 825693500.
Stockholders' approval obtained at annual meeting on May 21, 2026.

Key facts

Extracted from this filing and checked against the source text.

Governance Changes SEC 8-K Item 5.03/5.05/5.06 confidence 0.9

Shuttle Pharmaceuticals Holdings, Inc.: Filed a certificate of amendment to effect a 1-for-10 reverse stock split of common stock (effective 2026-06-11).

Change: charter amendment
Effective: 2026-06-11

Exact text from the filing

on June 10, 2026, the Company filed a certificate of amendment to amend the certificate of incorporation of the Company (the “Certificate of Amendment”) with the Secretary of State of the State of Delaware, with an effective date of June 11, 2026 (the “Effective Date”).

View on SEC.gov

256 governance changes filed in the last 30 days. Browse all governance changes →

Shuttle Pharmaceuticals Holdings, Inc. filing history →

Source: SEC EDGAR

accession 0001493152-26-028301

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.